The largest database of trusted experimental protocols

Fc blocking buffer

Manufactured by BioLegend

Fc blocking buffer is a solution used to block non-specific Fc receptor binding in immunoassays. It helps reduce background signal and improve the specificity of antibody-based detection.

Automatically generated - may contain errors

2 protocols using fc blocking buffer

1

Characterization of Microvesicle Composition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Composition and cell origin of MVs was done as described [35 (link), 36 (link)]. Briefly, MVs were permeabilized with Fix/Perm buffer (Biolegend), incubated with Fc blocking buffer (Biolegend), and labeled using antibodies to HMGB1, GFAP (astrocytes), Na+/K+ ATPase α3 (neurons), and CD11b (microglia). Samples are incubated with fluorescent secondary antibodies when appropriate. The Stratedigm S1000Ex was used to assess the stained MVs at the UNC Flow Cytometry Core Facility. Size gates to identify MVs (0.1–1.0 μm) were set using MegaMixTM (BioCytex) size gating beads (Additional file 1: Figure S1A). Single color controls for each primary antibody, compared to unstained media, were used to develop the compensation matrix and distinguish background staining from specific staining using FloJoTM software version 10.0 (Additional file 1: Figure S1B). Approximately 5% of the MVs stained positive for lactadherin, which binds phosphotidyl-serine (PS). Of the PS+ MVs, ethanol increased HMGB1 in a dose-dependent fashion up to 123% of controls at 75 mM (not shown).
+ Open protocol
+ Expand
2

Comprehensive Immunophenotyping of Airway Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Surface markers on fresh airway cells were labeled prior to fixation for optimal labeling as described previously [12 (link)]. Metal-conjugated antibodies (Table S1) for labeling cells were purchased (Fluidigm, Markham, ON), or carrier-free antibodies were conjugated in house using MaxPar X8 labeling kits according to manufacturer’s instructions (Fluidigm). EPX antibody was the generous gift of Elizabeth Jacobsen, PhD from the Mayo Clinic, Scottsdale, AZ [22 (link)]. Briefly, cells were washed with CyFACS buffer (PBS with 0.1% BSA, 2 nM EDTA, 0.05% Na azide; Maxpar® Cell Staining Buffer; Fluidigm, South San Francisco, CA), resuspended in 5 μM cisplatin (Enzo Life Sciences) for 5 minutes, and quenched with 100% FBS. Samples were incubated with 11% Fc blocking buffer (Biolegend, Dedham, MA), surface labeled for 30 min on ice, fixed (BD FACS Lyse), and frozen at -80°C. Intracellular labeling was conducted on batches of samples (10–20/day). Fixed cells were permeabilized (BD FACS Perm II) for labeling with intracellular antibodies for 45 min on ice. Cells were suspended overnight in iridium interchelator (125 nM; Fluidigm) in 2% paraformaldehyde in PBS and washed 1X in PBS and 2X in H2O immediately before acquisition. Samples were run on Helios 2 CyTOF instrument at a flow rate of 30 μL/min and a minimum of 100,000 events was collected.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!